Mpox: NCDC confirms case in Enugu, Ebonyi as rate declines

The Nigeria Centre for Disease Control, NCDC, says the number of suspected and confirmed Mpox cases in the country has declined over the past four weeks.

The NCDC made this disclosure via its official website on Monday.

DAILY POST reports that Mpox is an infectious viral disease that can occur in humans and other animals.

Symptoms include a rash that forms blisters, fever and swollen lymph nodes.

The illness is usually mild, and most infected individuals recover within a few weeks without treatment.

The public health agency in its latest data, said 51 new suspected cases were reported between Epidemiological (Epi) weeks 29 to 32 of 2024.

According to the NCDC, it was a significant drop from the 102 cases reported during the previous four weeks (Epi Week 25 to 28).

The agency said that the cases were recorded across 26 local government areas in 18 states, adding that out of the new suspected cases, two were confirmed positive, with one case each reported in Ebonyi and Enugu.

It further stated that this also marked a decrease from the seven confirmed cases recorded in the earlier period.

“The following outlined case definitions for suspected Mpox cases are an acute illness with fever 38.3°C, intense headache, lymphadenopathy, back pain, and myalgia.

“Intense asthenia is followed one to three days later by a progressively developing rash often beginning on the face and spreading to other parts of the body,” it said.

It described probable case as a case that meets the clinical case definition, not laboratory-confirmed but has an epidemiological link to a confirmed case.

“A confirmed case is a clinically compatible case that is laboratory-confirmed.

“Contact is any person who has been in direct or indirect contact with a confirmed case since the onset of symptoms,” it said.

The NCDC highlighted that in 2024 alone, Mpox had been confirmed in 19 states and the Federal Capital Territory (FCT), affecting 30 local government areas.

It said that the Case Fatality Rate for Mpox was calculated based on confirmed cases only.

To prevent the spread of Mpox, the NCDC advised the public to avoid close contact with individuals showing symptoms, particularly those with rashes or skin lesions.

It urged healthcare providers to be vigilant for patients presenting fever, rash, and other mpox symptoms, especially if they have a history of travel to affected areas or contact with suspected cases.

The NCDC said that the National Mpox Technical Working Group (TWG), comprising multi-sectoral and multi-partner teams, continued its efforts to monitor and respond to the outbreak across the nation.

The public health agency urged Nigerians to remain vigilant and adhere to public health guidelines to curb the spread of Mpox, particularly in affected states.